This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: monoclonal antibody
Check out our new article: ‘Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations’ (Advanced Drug Delivery Reviews – Open Access)
May 23, 2025Publication: Laura Pineiro-Alonso, Inés Rubio-Prego, Alexandra Lobyntseva, Eva González-Freire, Robert Langer, María José Alonso, Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations, Advanced Drug Delivery Reviews, Volume 222, 2025, 115606, ISSN 0169-409X, https://doi.org/10.1016/j.addr.2025.115606
Read More
Check out our new article: ‘Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors’ – OPEN ACCESS
July 19, 2024Ana M. López-Estévez, Lucía Sanjurjo, Ángela Turrero, Iker Arriaga, Nicola G.A. Abrescia, Ana Poveda, Jesús Jiménez-Barbero, Anxo Vidal, Dolores Torres, María José Alonso, Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors, Journal of Controlled Release, Volume 373, 2024, Pages 277-292, ISSN 0168-3659,
https://doi.org/10.1016/j.jconrel.2024.07.032
Check out our new article: ‘Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights’ – OPEN ACCESS
July 12, 2024López-Estévez, A.M., Zhang, Y., Medel, M. et al. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights. Nano Res. (2024). https://doi.org/10.1007/s12274-024-6826-8
Read More